Calculated
DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
449.74 USD420.36 USD527.07 USD
-31.35%
420.36 USDCurrent price is 31.3% below the base model value.
C
US
CI.US · Cigna Group
US · US
Latest price288.60 USD
30D+5.57%
Vs. base value-31.3%
Research summary
CI.US latest organized financial period shows revenue grew +11.24% YoY and net income grew +73.47% YoY. Current price is about 289 USD, while the model base case is about 420 USD; the current price sits -31.3% versus the base case. The page shows both reported and adjusted views; valuation still defaults to reported figures, while adjusted figures help isolate structured one-time-item impact. This summary is intended for public-information research and model review.
Key financial trend
Annual financial metrics with switchable views. · Unit: USD
Revenue275B USD
Net income6B USD
Free cash flow10B USD
Operating cash flow10B USD
Price trend
Price date: 2026/04/29 · Updated: 2026/04/29 15:26
Valuation model range
Hover each model row to inspect formulas and inputs.
Current price288.60 USD
Base value420.36 USD
Vs. base-31.3%
Price date2026/04/29
444.25 USD420.36 USD527.07 USD
-31.35%
Calculated
Owner Earnings
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
444.25 USD718.72 USD936.50 USD
-59.85%
718.72 USDCurrent price is 59.8% below the base model value.Adjusted reference: 501.56 USD
Calculated
Reverse DCF
Solves the forward FCF growth rate implied by the current price.
Implied growth-7.1%
Current price implies roughly -7.1% annualized FCF growth.
-7.1%Current price implies roughly -7.1% annualized FCF growth.
Calculated
Earnings Power Value
Estimates earnings power value without assuming growth.
295.81 USD295.81 USD295.81 USD
-2.44%
295.81 USDCurrent price is close to the base model value.
Updated: 2026/04/29 15:26
Valuation basis and non-recurring items
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
ExpandCollapse
Valuation basis and non-recurring items
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
| Period | Item | Category | After-tax impact | Confidence |
|---|---|---|---|---|
| 2025/12/31 | Business sale gain/loss | Asset sale gain/loss | 10M USD | Medium |
| 2024/12/31 | Business sale gain/loss | Asset sale gain/loss | 38M USD | Medium |
| 2023/12/31 | Business sale gain/loss | Asset sale gain/loss | -4B USD | Medium |
| 2023/12/31 | Restructuring charges | Restructuring | -398M USD | Medium |
| 2022/12/31 | Business sale gain/loss | Asset sale gain/loss | 4B USD | Medium |
| 2022/12/31 | Restructuring charges | Restructuring | -52M USD | Medium |
| 2021/12/31 | Restructuring charges | Restructuring | -531M USD | Medium |
| 2020/12/31 | Business sale gain/loss | Asset sale gain/loss | 10B USD | Medium |
| 2025/09/30 | Business sale gain/loss | Asset sale gain/loss | 92M USD | Medium |
| 2025/09/30 | Restructuring charges | Restructuring | -623M USD | Medium |
| 2025/06/30 | Business sale gain/loss | Asset sale gain/loss | 32M USD | Medium |
| 2025/06/30 | Restructuring charges | Restructuring | -374M USD | Medium |
| 2025/03/31 | Business sale gain/loss | Asset sale gain/loss | 32M USD | Medium |
| 2025/03/31 | Restructuring charges | Restructuring | -170M USD | Medium |
| 2024/09/30 | Business sale gain/loss | Asset sale gain/loss | -305M USD | Medium |
| 2024/06/30 | Business sale gain/loss | Asset sale gain/loss | -30M USD | Medium |
| 2024/03/31 | Business sale gain/loss | Asset sale gain/loss | -30M USD | Medium |
Ad placement
Quarterly and annual financial table
Financial DetailsShowing latest 5 / 14
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2025/12/31 | Annual | 275B USD | 6B USD | 6B USD | 10B USD | 22.18 | 22.14 |
| 2024/12/31 | Annual | 247B USD | 3B USD | 3B USD | 10B USD | 12.12 | 11.99 |
| 2023/12/31 | Annual | 195B USD | 5B USD | 9B USD | 12B USD | 17.39 | 30.69 |
| 2022/12/31 | Annual | 181B USD | - | - | 9B USD | 21.3 | 6.83 |
| 2021/12/31 | Annual | 174B USD | - | - | 7B USD | 15.73 | 17.71 |
Ad placement